Zhang, S., Mao, X., Wang, H., Cai, F., & Xu, J. (2016). Efficacy and safety of bevacizumab plus erlotinib versus bevacizumab or erlotinib alone in the treatment of non-small-cell lung cancer: A systematic review and meta-analysis. BMJ Open.
Chicago Style CitationZhang, Shu, Xiao-dong Mao, Hai-tao Wang, Feng Cai, and Jing Xu. "Efficacy and Safety of Bevacizumab Plus Erlotinib Versus Bevacizumab or Erlotinib Alone in the Treatment of Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis." BMJ Open 2016.
MLA CitationZhang, Shu, et al. "Efficacy and Safety of Bevacizumab Plus Erlotinib Versus Bevacizumab or Erlotinib Alone in the Treatment of Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis." BMJ Open 2016.
Warning: These citations may not always be 100% accurate.